Healthcare - Biotechnology - NASDAQ - US
$ 4.41
-8.51 %
$ 235 M
Market Cap
-4.64
P/E
INCOME STATEMENT
21 M
REVENUE
-93.5 M
OPERATING INCOME
-89.2 M
NET INCOME
EFFICIENCY
Earnings Waterfall
TScan Therapeutics, Inc.
| Revenue | 21 M |
| Cost Of Revenue | 88.2 M |
| Gross Profit | -67.1 M |
| Operating Expenses | 115 M |
| Operating Income | -93.5 M |
| Other Expenses | -4.24 M |
| Net Income | -89.2 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 21.0 | 13.5 | 10.1 | 1.1 | 0 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 88.2 | 5.1 | 3.3 | 20.6 | 0.5 |
| Gross Profit | (67.1) | 8.4 | 6.8 | (19.5) | (0.5) |
| OPERATING INCOME | |||||
| Operating Expenses | 114.5 | 80.2 | 58.8 | 27.3 | 14.2 |
| Selling, General and Administrative Expenses | 26.4 | 20.4 | 13.8 | 6.7 | 4.8 |
| Research and Development Expenses | 88.2 | 59.8 | 45.0 | 20.6 | 9.4 |
| Operating Income | (93.5) | (66.6) | (48.6) | (26.2) | (14.2) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 3.8 | 1.2 | 0 | 0 | 0 |
| Total Other Income | 4.2 | 0.4 | 16 K | 0.1 | 0.6 |
| Pre-Tax Income | (89.2) | (66.2) | (48.6) | (26.1) | (13.7) |
| NET INCOME | |||||
| Tax Provision | 0 | (0.4) | 3.1 | (0.1) | (0.6) |
| Net Income | (89.2) | (65.8) | (48.6) | (26.0) | (13.1) |
| EPS | 1.36 | 2.74 | 2.03 | 1.04 | 0.53 |